MF

Melissa Fleury

TI Theravance Biopharma R&D Ip: 74 patents #2 of 116Top 2%
TH Theravance: 10 patents #49 of 116Top 45%
TC Theravance Respiratory Company: 8 patents #7 of 9Top 80%
IB Ideaya Biosciences: 3 patents #7 of 23Top 35%
GS Gilead Sciences: 1 patents #673 of 952Top 75%
📍 Brisbane, CA: #2 of 188 inventorsTop 2%
🗺 California: #2,419 of 386,348 inventorsTop 1%
Overall (All Time): #15,731 of 4,157,543Top 1%
96
Patents All Time

Issued Patents All Time

Showing 26–50 of 96 patents

Patent #TitleCo-InventorsDate
10570120 Neprilysin inhibitors Adam D. Hughes 2020-02-25
10548879 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2020-02-04
10526330 JAK kinase inhibitor compounds for treatment of respiratory disease Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Lan Jiang, Cameron Smith +3 more 2020-01-07
10472335 Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Adam D. Hughes, Miroslav Rapta, Venkat R. Thalladi, R. Michael Baldwin, David L. Bourdet 2019-11-12
10358433 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more 2019-07-23
10315984 Neprilysin inhibitors Adam D. Hughes 2019-06-11
10189823 Neprilysin inhibitors Adam D. Hughes 2019-01-29
10172834 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2019-01-08
10138220 Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more 2018-11-27
10130642 Neprilysin inhibitors Roland Gendron, Adam D. Hughes 2018-11-20
10123984 Neprilysin inhibitors Adam D. Hughes, Erik Fenster, Roland Gendron, Edmund J. Moran 2018-11-13
10100021 Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Adam D. Hughes, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone 2018-10-16
10100049 JAK kinase inhibitor compounds for treatment of respiratory disease Paul R. Fatheree, John R. Jacobsen, Anne-Marie Beausoleil, Gary E. L. Brandt, Lan Jiang +3 more 2018-10-16
10053417 Neprilysin inhibitors Erik Fenster, Adam D. Hughes 2018-08-21
10028960 Pyrimidine compounds as JAK kinase inhibitors Ryan Hudson, Jennifer Kozak, Paul R. Fatheree, Anne-Marie Beausoleil, Dante D. Podesto 2018-07-24
10005740 Neprilysin inhibitors Anne-Marie Beausoleil, Adam D. Hughes, Daniel D. Long, Donna A. A. Wilton 2018-06-26
9981999 Neprilysin inhibitors Adam D. Hughes 2018-05-29
9975875 Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more 2018-05-22
9884807 Neprilysin inhibitors Adam D. Hughes 2018-02-06
9873685 Neprilysin inhibitors Adam D. Hughes 2018-01-23
9872855 (2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2018-01-23
9868698 (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid Adam D. Hughes, Erik Fenster, Anne-Marie Beausoleil, Venkat R. Thalladi, Jerry Nzerem +1 more 2018-01-16
9845332 Neprilysin inhibitors Roland Gendron, Adam D. Hughes 2017-12-19
9840460 Neprilysin inhibitors Erik Fenster, Adam D. Hughes 2017-12-12
9839639 Neprilysin inhibitors Anne-Marie Beausoliel, Adam D. Hughes, Daniel D. Long, Donna A. A. Wilton 2017-12-12